Ligand · VLD
VLD · (2S)-2-({4-[({(6R)-2,4-diamino-5-[(1-{(2R,4S,5R)-4-hydroxy-5-[(phosphonooxy)methyl]tetrahydrofuran-2-yl}-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methyl]-5,6,7,8-tetrahydropyrido[3,2-d]pyrimidin-6-yl}methyl)amino]benzoyl}amino)pentanedioic acid (non-preferred name)
VLD, (2S)-2-({4-[({(6R)-2,4-diamino-5-[(1-{(2R,4S,5R)-4-hydroxy-5-[(phosphonooxy)methyl]tetrahydrofuran-2-yl}-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methyl]-5,6,7,8-tetrahydropyrido[3,2-d]pyrimidin-6-yl}methyl)amino]benzoyl}amino)pentan…
- Component
- VLD
- Formula
- C30 H38 N9 O13 P
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
VLD in 1 structure; the first of them:
- 7JX1 · E. coli TSase complex with a bi-substrate reaction intermediate analog · VLD B301 · binds ARG126, ARG21, HIS51, SER54, ILE79, TRP80, TRP83, TYR94 and 16 more
Residues it binds most
ARG 1, HIS 1, CYS 1, LEU 1, SER 1, TRP 1, TYR 1, ALA 1, ASN 1, ASP 1 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.